Skip to content

Safety and Effectiveness of Remifentanil and Sevoflurane for Maintaining General Anesthesia in Different Surgical Procedures — A Single-Center, Prospective Randomized Controlled Trial

Safety and Effectiveness of Remifentanil and Sevoflurane for Maintaining General Anesthesia in Different Surgical Procedures — A Single-Center, Prospective Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129161
Enrollment
Unknown
Registered
2026-07-31
Start date
2026-08-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

general anesthesia surgery

Interventions

Propofol Group:Provide maintenance with propofol during surgery
Sevoflurane group:Provide maintenance with sevoflurane during surgery

Sponsors

North China University of Science and Technology Affiliated Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 18–80 years, no gender restriction. 2. Planned elective surgery requiring tracheal intubation and intraoperative anesthesia maintenance under general anesthesia. 3. ASA classification I–III. 4. Expected surgery duration >=2 hours. 5. Able to understand the procedures and methods of this study, willing to sign the informed consent form, and strictly comply with the clinical research protocol to complete this study.

Exclusion criteria

Exclusion criteria: 1. Emergency surgery or inability to complete preoperative evaluation. 2. Known allergy/contraindication to remifentanil, sevoflurane, or study-related drugs. 3. Severe cardiac or pulmonary dysfunction (such as decompensated heart failure, severe arrhythmia, severe respiratory failure) deemed unsuitable for enrollment by the investigator. 4. Severe hepatic or renal dysfunction (such as Child-Pugh C, or end-stage renal disease requiring dialysis). 5. Obvious preoperative neuropsychiatric abnormalities or severe cognitive impairment that prevents completion of postoperative assessments and follow-ups. 6. Pregnant or breastfeeding women. 7. Participation in other interventional clinical trials in the past 3 months that may affect the outcomes of this study. 8. Investigator judges poor compliance, unable to complete follow-up according to the protocol.

Design outcomes

Primary

MeasureTime frame
Total Quality of Recovery-15 score at 24 hours after surgery;

Countries

China

Contacts

Public ContactMa Wei

North China University of Science and Technology Affiliated Hospital

1194688049@qq.com+86 315 5828227

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026